19 November 2019 - Senator John Thune, the Senate’s No. 2 Republican, said Tuesday that it is unlikely the Senate will pass legislation to lower drug prices before the end of the year.

“I think it would be the triumph of hope over experience to think that we could get it done before the end of the year, but there's a lot of interest in doing something on drug pricing,” Thune told reporters on Tuesday.

Lowering drug prices has been seen as a rare possible area of bipartisan accomplishment, but the effort is running into obstacles and a range of competing plans.

Read The Hill article